Skip to main content
. 2023 Aug 30;15(17):4334. doi: 10.3390/cancers15174334

Figure 1.

Figure 1

Flowchart of national patient selection for commercially available CD19-directed CAR-T therapy: all patients referred to the Dutch CAR-T tumorboard between May 2020 until May 2022 and reasons for ineligibility. Abbreviations: CNS: central nervous system, ECOG: Eastern Cooperative Oncology Group, LBCL: large B-cell lymphoma.